• News
    March 22, 2018

    Cimzia Label Update Provides New Information For Women Of Childbearing Age

    The FDA approved a label update of UCB's Cimzia, or certolizumab pegol, to include new data showing a negligible to low risk for drug transfer through plac…

    Read Article